Molecular Partners Ag (MOLN) Revenue (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Revenue for 7 consecutive years, with $17166.8 the latest figure, recorded in Q1 2026.

• Quarterly Revenue fell 4.38% year-over-year to $17166.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3716.7 (up 100.0% YoY) and the FY2025 annual result came in at $72.69, down 100.0% from the prior year.
• Revenue rose to $17166.8 in Q1 2026 per MOLN's latest filing, from -$56858.0 in the prior quarter.
• Over the last five years, Revenue for MOLN reached as high as $3.3 billion in Q1 2023 and fell as low as -$5.7 billion in Q4 2024.
• A 5-year average of $199.5 million and a median of $20917.0 in 2025 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue soared 63614439.0% — and 2024, when it tumbled 71593.16%.
• Year by year, Revenue stood at $155.5 million in 2022, then sank by 94.9% to $7.9 million in 2023, then slumped by 71593.16% to -$5.7 billion in 2024, then soared by 100.0% to -$56858.0 in 2025, then surged by 130.19% to $17166.8 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $17166.8, -$56858.0, and $15057.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.